GC Biopharma Corp. (KRX:006280)

Market Cap	1.53T +12.3%
Revenue (ttm)	1.99T +18.5%
Net Income	-4.67B
EPS	-410.00
Shares Out	11.41M
PE Ratio	n/a
Forward PE	40.11
Dividend	1,500.00 (1.12%)
Ex-Dividend Date	Mar 30, 2026

Volume	28,969
Average Volume	61,452
Open	133,100
Previous Close	134,300
Day's Range	130,100 - 134,900
52-Week Range	123,200 - 183,800
Beta	0.75
RSI	39.68
Earnings Date	May 22, 2026

About GC Biopharma

GC Biopharma Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Country: South Korea
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 006280

Financial Performance

In 2025, GC Biopharma's revenue was 1.99 trillion, an increase of 18.54% compared to the previous year's 1.68 trillion. Losses were -4.67 billion, -82.22% less than in 2024.